JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 688076 for the last quarter is 417.64 M CNY, and it's 11.58% lower compared to the previous quarter. The net income of Q3 24 is 123.09 M CNY.